Role of malondialdehyde (MDA) in patients with breast cancer diseases

  • Eti Yerizel Department of Biochemistry, Faculty of Medicine Andalas University, Padang
  • Niki Astria Department of Midwifery, Faculty of Medicine Andalas University, Padang
  • Daan Khambri Department of Surgery, Faculty of Medicine Andalas University, dr. M.Djamil Hospital, Padang
Keywords: Breast Cancer, Malondialdehyde


Background: Breast cancer is one of the most common cancers as well as one of the leading causes of cancer mortality in women worldwide. Cancer risk potentially continues to increase because of the many sources of exposure to carcinogenic chemical compounds. Carcinogenic compounds can contribute to free radical formation which might further interact and damage biomolecules such as lipids. Lipid peroxidation will increase malondialdehyde (MDA) levels, triggering gene mutations that leads to cancer.  

Objective: The purpose of this research was to measure and compare MDA levels between breast cancer patients and control.

Methods: This research was observational research using a cross-sectional comparative design of 30 breast cancer patients and 30 healthy controls. The place of this research is in Ropanasuri specialized surgery hospital and biochemical laboratory,  Faculty of Medicine, Andalas University, Padang. This research was conducted from August to September 2019. The MDA was measured using a spectrophotometer and an independent T-test was done.

Results: The result of this research showed the mean MDA level of breast cancer patients was 3.98 ± 0.35 nmol/ml, higher than controls was 3.04 ± 0.36 nmol/ml with p-value = 0.001.

Conclusion: There were significant differences in MDA levels among breast cancer patients and control in Ropanasuri specialized surgery hospital, Padang.


Sun Y, et al. Risk factors and preventions of breast cancer. Internasional Journal of Biological Sciences. 2017; 13(11): 1387-1397.

World Helath Organization WHO. (2016). Breast cancer:prevention and control. Available from: (Accessed 30 Maret 2019).

Sonnenschein C, Soto AM. Carcinogenesis explained within the context of a theory of organisms. Progress in biophysics and molecular biology. 2016;122(1): 70-76.

Dumars C, Ngyuen JM, Gaultier A, et al. Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma. Oncotarget. 2016; 7(48): 78343-54.

Basse C, Arock M. The increasing roles of epigenetics in breast cancer: Implications for pathogenicity, biomarkers, prevention and treatment. Int J Cancer. 2015; 137 (12):2785-2794.

World Helath Organization WHO. (2018). Cancer. Available from: (Accessed 08 Juli 2019).

Torre AL. Surveilance and health services research. Atlanta: American cancer Society. 2016;14: 16-27.

Desantis CE, et al. Breast cancer statistics 2015: Convergence of Incidence rates between black and white women. CA Cancer J Clin. 2016; 66 (01): 31-42.

International Agency for Research on Cancer (IARC). Latest world cancer statistics global cancer burden rises to 14.1 million new cases in 2012: marked increase in breast cancers must be addressed. Lyon: International Agency Of Research on Cancer. 2012; (12).

Harahap WA. Cancer epidemiology & cancer risk factors. Surgery departemen. Andalas Medical School. 2016; 12 (8):1-8.

Askoxylakis V, et al. Long-term survival of cancer patients compared to heart failure and stroke: A systematic review. BMC Cancer. 2010; 10 (15):1-8.

Gubaljević JG, et al. Serum levels of oxidative stress marker malondialdehyde in breast cancer patients in relation to pathohistological factors, estrogen receptors, menopausal status, and age. Journal of Health Sciences. 2018;8(3):154-161.

Ayala, A. Munoz, MF. Arguelles, S. Lipid Peroxidation: Production, metabolism and signaling mechanism of malondialdehyde and 4-Hydroxy-2-nonenal. Oxid med Cell Longev. 2010;112 (20): 1-31.

Asni E, et al. Pengaruh hipoksia berkelanjutan terhadap kadar malondialdehid, glutation tereduksi, dan aktivitas katalase ginjal tikus. Majalah Kedokteran Indonesia. 2009; 59 (12): 595-600.

Yusrika AR. Aulanni'am. Prasetyawan, S. Kadar malondialdehid (MDA) dan gambaran histologi pada ginjal tikus putih (Rattus norvegicus) pasca induksi cylosporine-A. Kimia Student Journal. 2013;1 (02) : 222-228.

Ma B, Villalta PW, Balbo S, Stepanov I. Analysis of a malondialdehyde-Deoxyguanosine adduct in human leukocyte DNA by liquid chromatography nanoelectrospray-high-resulation tandem mas spectrometry. Chemical Research in Texicology. 2010; 27 (10) : 1829-1836.

Wang J, et al. Inhibition of cancer growth in vitro and vivo by a novel ROS-modulating agent with ability to eliminate stem-like cancer cells. Offocial Journal of the Cell death Differentiation Association. 2017;8 : 1-9.

Thangjam S, Laishram RS, Debnath K. Breast carcinoma in young females below the age of 40 years: a hispathological perspective. South Asian Journal of Cancer. 2014; 3 (02) : 97-100.

Rahmatya A, Khambri D. Hubungan usia dengan gambaran klinikopatologi kanker payudara di bagian bedah RSUP Dr. M.Djamil Padang. Jurnal Kesehatan Andalas. 2015; 4 (2): 479-484.

Bhattacharjee, J. Jogdand, S. Shinde, RK. Goswami, S. Assessment of oxidative stress in breast cancer patients: a Hospital based study. Internasional Journal of Basic & Clinical Pharmacology. 2018;7 (5): 966-970.

Kumari S, Badana AK, G MM, G S, Malla R. Reactive oxygen species: A key constituent in cancer survival. Biomark Insights. 2018;13: 1177271918755391.

Hauck AK, Bernlohr DA. Oxidative stress and lipotoxicity. Journal of Lipid Research. 2016; 57 (31) : 1976.

Sahu A, Varma M, Kachhawa K. A Prognostic study of MDA, SOD and Catalase in Breast Cancer Patients. Internasional Journal of Science and Research. 2013; 4 (05) : 157-159.

How to Cite
Yerizel, E., Astria, N., & Khambri, D. (2019). Role of malondialdehyde (MDA) in patients with breast cancer diseases. Acta Biochimica Indonesiana, 2(2), 68-74.